期刊文献+

HCMV活动性感染与尿路上皮癌的相关性研究 被引量:7

The correlation study of HCMV active infection and urothelial carcinoma
暂未订购
导出
摘要 目的分离和鉴定尿路上皮癌患者的肿瘤组织和抗凝血标本中人巨细胞病毒(HCMV),结合临床资料分析比较HCMV活动性感染与尿路上皮癌发生发展及其复发的相关性。方法采集33例经病理检测确诊为尿路上皮癌患者的组织和血标本,进行如下处理:分别采用细胞培养病毒分离法进行病毒分离;PCR法检测患者的抗凝血及组织DNA标本中HCMV UL55和UL83基因;IFA法检测抗凝血标本中HCMV pp65抗原;ELISA法检测HCMV IgG及IgM抗体;记录分析结果,确定尿路上皮癌患者HCMV活动性感染率。结果在33份抗凝血标本中,分离到1株临床分离株,该标本经盲传3代出现典型HCMV特征性细胞病变效应(CPE),经鉴定为HCMV。HCMV UL55和UL83基因、HCMV pp65抗原血症及HCMV IgM抗体检测均为阳性的有6份,因此可以判定在33例尿路上皮癌患者中,HCMV活动性感染者有6例,活动性感染率为18.2%(6/33)。结合患者的临床资料进一步分析发现,尿路上皮癌患者复发及病理分级均与HC-MV活动性感染相关,且HCMV活动性感染者其病理分级程度升高。结论结合临床资料分析发现,尿路上皮癌复发及病理分级程度升高均与HCMV活动性感染有关。 Objective To isolate and identify the HCMV among the cancerous tissue and anticoagulant blood from the patients with urothelial carcinoma,and to analyze the correlation of HCMV activated infection and urothelial carcinoma progression,especially recurrence.Methods The tissue and blood samples were collected in 33 patients who were identified as urothelial carcinoma with pathologic diagnosis.We performed the cell culture to isolate the virus,the PCR to detect the HCMV UL55 and UL83 gene,the IFA to identify the HCMV pp65 antigen among blood samples,and the ELISA to detect the HCMV IgG and IgM,and analyzed the data.Moreover,to identify the HCMV active infection rate in patients with urothelial carcinoma.Results There was one clinical isolate line among 33 anticoagulant specimens,and the specimen was characteristic of HCMV CPE via three generations,which was identified as HCMV.There were 6 specimens positive with HCMV UL55,UL83 gene,HCMV pp65 antigenemia and HCMV IgM,so we determined HCMV active infection cases were 6 and active infection rate was 18.2%(6/33).We further demonstrated recurrence and pathological grade were both related to HCMV active infection and the pathological grading was elevated in HCMV active infector.Conclusion The recurrence and pathologic further grading of urothelial carcinoma is closely linked with HCMV active infection.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第1期60-65,共6页 Acta Universitatis Medicinalis Anhui
关键词 尿路上皮癌 人巨细胞病毒 HCMV活动性感染 urothelial carcinoma HCMV HCMV active infection
  • 相关文献

参考文献13

  • 1周清,姚善华,韩海彬,李彦峰.预防膀胱癌术后复发的研究进展[J].重庆医学,2011,40(24):2465-2467. 被引量:22
  • 2秦逸秋,张云英,沈红,王文静,钟淑梅,李延红,阮素云.膀胱癌患者尿脱落细胞中人巨细胞病毒的定量分析[J].劳动医学,2001,18(3):151-153. 被引量:2
  • 3Cazzaniga P,Vercillo R,Gradilone A,et al. Prevalence of papillo-mavirus ,epstein-Barr virus, cytomegalovirus, and herpes simplexvirus Type 2 in Urinary Bladder Cancer[ J] . J Med Virol,1998,55(4):262-7.
  • 4Lukacsi A, Tarodi B, Endreffy E. Human cytomegalovirus gBgenotype 1 is dominant in congenital infections in South Hungary[J]. J Med Virol, 2001,65(3) :537 -42.
  • 5金艳,邓松华,王明丽.人巨细胞病毒先天性感染实验室诊断的研究进展[J].安徽医科大学学报,2011,46(3):282-285. 被引量:22
  • 6Paixao P,Almeida S, Gouveia P, et al. Prevalence of human cy-tomegalovirus congenital infection in Portuguese newborns [ J ]. Eu-ro SurveiU,2009,14(9) :13 -5.
  • 7Giuliani L,Jaxmar T, Casadio C,et al. Detection of oncogenic vi-ruses (SV40,BKV,JCV,HCMV,HPV) and p53 codon 72 pol-ymorphism in lung carcinoma[ J]. Lung cancer,2007,57(3) :273-81.
  • 8崔寰,王明丽.人巨细胞病毒感染与肿瘤相关性研究进展[J].微生物与感染,2008,3(3):166-169. 被引量:7
  • 9Roubalov6 K, Strunecka 0,Zufanovd S,et al. Genotyping of viralglycoprotein B ( gB) in hematopoietic stem cell transplant recipi-ents with active cytomegalovirus infection : analysis of the impact ofgB genotypes on the patients ^ outcome [ J ]. Epidemiol MikrobiolImunol, 2010,59(2):92-9.
  • 10Zawilinska B, Szostek S, Kope J,et al. ML55 genotype diversityof cytomegalovirus strains isolated from newborns and infants hospi-talized in southern Poland[ J]. Przegl Epidemiol,2011,65 (3 ):409-13.

二级参考文献45

共引文献47

同被引文献121

  • 1李法锦,施浩强,唐亮,张涛,樊松,江长琴,葛俊,王明丽,梁朝朝.人巨细胞病毒感染对围手术期尿路上皮癌患者免疫功能的影响[J].肿瘤防治研究,2014,41(2):119-123. 被引量:4
  • 2汤智勇,陈华,李倩,邓乐方,陈立华.人类巨细胞病毒感染与结肠癌相关关系的初步研究[J].实用预防医学,2007,14(3):688-690. 被引量:2
  • 3Koji Kawai,Jun Miyazaki,Akira Joraku,Hiroyuki Nishiyama,Hideyuki Akaza.B acillus C almette– G uerin ( BCG ) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine[J]. Cancer Sci . 2013 (1)
  • 4Tahlita C.M. Zuiverloon,Annemieke J.M. Nieuweboer,Hedvig Vékony,Wim J. Kirkels,Chris H. Bangma,Ellen C. Zwarthoff.Markers Predicting Response to Bacillus Calmette-Guérin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review[J]. European Urology . 2011 (1)
  • 5Krech U. Complement-fixing antibodies against cytomegalovirus in different parts of the world[J]. Bull World Health Organ, 1973,49(1): 103-106.
  • 6Soderberg-Naucler C. Does cytomegalovirus playa causative role in the development of various inflammatory diseases and cancer?[J]. J Intern Med, 2006, 259(3): 219-246.
  • 7Fisher RA. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation[J]. Transpl Infect Dis, 2009, 11(3): 195-202.
  • 8Bego MG, St Jeor S. Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency[J]. Exp Hematol, 2006, 34(5): 555-570.
  • 9Samanta M, Harkins L, Klemm K, et al. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma[J]. J Urol, 2003, 170(3): 998-1002.
  • 10Cobbs CS, Harkins L, Samanta M, et al. Human cytomegalovirus infection and expression in human malignant glioma[J]. Cancer Res, 2002, 62(12): 3347-3350.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部